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Abstract
Noble gas pulmonary magnetic resonance imaging (MRI) is transitioning
away from 3He to 129Xe gas, but the physiological/clinical relevance of 129Xe
apparent diffusion coefficient (ADC) parenchyma measurements is not well
understood. Therefore, our objective was to generate 129Xe MRI ADC for
comparison with 3He ADC and with well-established measurements of alveolar structure and function in older never-smokers and ex-smokers with
chronic obstructive pulmonary disease (COPD). In four never-smokers and 10
COPD ex-smokers, 3He (b = 1.6 sec/cm2) and 129Xe (b = 12, 20, and 30 sec/
cm2) ADC, computed tomography (CT) density-threshold measurements, and
the diffusing capacity for carbon monoxide (DLCO) were measured. To understand regional differences, the anterior–posterior (APG) and superior–inferior
(ΔSI) ADC differences were evaluated. Compared to never-smokers, COPD
ex-smokers showed greater 3He ADC (P = 0.006), 129Xe ADCb12 (P = 0.006),
and ADCb20 (P = 0.006), but not for ADCb30 (P > 0.05). Never-smokers and
COPD ex-smokers had significantly different APG for 3He ADC (P = 0.02),
129
Xe ADCb12 (P = 0.006), and ADCb20 (P = 0.01), but not for ADCb30
(P > 0.05). ΔSI for never- and ex-smokers was significantly different for 3He
ADC (P = 0.046), but not for 129Xe ADC (P > 0.05). There were strong correlations for DLCO with 3He ADC and 129Xe ADCb12 (both r = 0.95,
P < 0.05); in a multivariate model 129Xe ADCb12 was the only significant
predictor of DLCO (P = 0.049). For COPD ex-smokers, CT relative area
<950 HU (RA950) correlated with 3He ADC (r = 0.90, P = 0.008) and 129Xe
ADCb12 (r = 0.85, P = 0.03). In conclusion, while 129Xe ADCb30 may be
appropriate for evaluating subclinical or mild emphysema, in this small group
of never-smokers and ex-smokers with moderate-to-severe emphysema, 129Xe
ADCb12 provided a physiologically appropriate estimate of gas exchange
abnormalities and alveolar microstructure.
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He ADC with 129Xe ADC (b = 12 sec/cm2) were
reported (Kirby et al. 2012d), significantly lower 129Xe as
compared to 3He MRI ventilation was observed in COPD
ex-smokers (Kirby et al. 2013) and asthmatics (Svenningsen et al. 2013). Regions of diminished 129Xe as compared
to 3He ventilation are spatially related to emphysematous
regions (Kirby et al. 2013) in COPD subjects.
It is important to consider the different self-diffusion
coefficients of 3He and 129Xe gases. For example, 129Xe
gas has a much lower diffusion coefficient than 3He and,
therefore, in order to achieve sufficient diffusion weighting for 129Xe MRI to derive meaningful lung microstructural information, appropriately large b values and
diffusion times must be applied (Sukstanskii and Yablonskiy 2012). However, increasing the diffusion weighting is
coupled with a reduction in image signal-to-noise ratio
(SNR); therefore it is important to experimentally demonstrate the 129Xe ADC b value that provides the optimal
balance between sensitivity to the lung microstructural
abnormalities and feasibility with respect to image SNR.
It is also essential to investigate the different 129Xe MRI
ADC b values and their associations with other emphysema measurements in order to better understand how
imaging estimates are related to physiological measurements in COPD patients. Previous studies have focused
on 129Xe ADC generated with a b value of 12 sec/cm2
(Kaushik et al. 2011; Kirby et al. 2012d), and therefore
here we aimed to (i) determine whether 129Xe ADC generated using b values of 12, 20, and 30 sec/cm2 and contemporaneously acquired 3He ADC (Kirby et al. 2013),
distinguishes older never-smokers from ex-smokers with
COPD, (ii) compare 3He and 129Xe ADC in the superior–
inferior (SI) and anterior–posterior (AP) lung regions to
better understand potential dependencies for b value with
regional ADC, and (iii) determine the significant associations of 129Xe ADC with b values of 12, 20, and 30 sec/
cm2 with DLCO and CT measurements of emphysema,
similar to those recently used in the COPDGene (Regan
et al. 2010), CanCOLD (Bourbeau and Saad 2013),
ECLIPSE (Vestbo and Anderson 2008), and SPIROMICS
(Couper et al. 2014) studies.
3

Introduction
Magnetic resonance imaging (MRI) using hyperpolarized
noble gases 3He and 129Xe provides high spatial and temporal resolution images of pulmonary gas distribution
(Kauczor et al. 1997; de Lange et al. 1999; Moller et al.
2002). Parenchymal microstructure can also be probed
using diffusion-weighted (DW) imaging. DW imaging
takes advantage of the gases rapid molecular diffusion to
generate 3He and 129Xe apparent diffusion coefficients
(ADCs; Saam et al. 2000; Salerno et al. 2002). Although
the first demonstrations of inhaled hyperpolarized gas
MRI used 129Xe gas (Albert et al. 1994; Mugler et al.
1997), until recently, most examinations in subjects with
chronic obstructive pulmonary disease (COPD) used 3He
gas mainly due to the nearly threefold higher gyromagnetic ratio and higher polarizations – both of which independently contribute to greater image quality for 3He
MRI. These previous studies showed that 3He ADC values
are reproducible in emphysematous subjects (Morbach
et al. 2005; Diaz et al. 2008; Mathew et al. 2008), sensitive
to lung microstructure and airspace size (Saam et al.
2000; Salerno et al. 2002), and correlate with spirometry
(Salerno et al. 2002; Diaz et al. 2009), diffusing capacity
of carbon monoxide (DLCO; Fain et al. 2006), and x-ray
computed tomography (CT) measurements of emphysema (Diaz et al. 2009). Importantly, 3He MRI ADC measurements were directly compared with stereological
measurements of fixed lung tissue and this showed the
high sensitivity of 3He MRI ADC to lung surface area
abnormalities in emphysematous tissue (Woods et al.
2006). Despite these important findings, 3He MRI is unlikely to be used clinically because of its relatively high cost
and low abundance (Fain et al. 2010). On the other hand,
129
Xe gas is substantially more abundant, relatively inexpensive, and clinical quantities may be polarized in 30–
60 min (Mugler et al. 1997, 2004). Because of this, there
is considerable interest in transitioning to 129Xe MRI.
Although 129Xe gas is capable of transmembrane diffusion (Cleveland et al. 2010) this leads to adverse systemic
effects when used in high concentrations; Xe has been
widely and safely used in pulmonary CT (Chae et al.
2008; Honda et al. 2012), cerebral blood flow imaging
(Carlson et al. 2011), and lung scintigraphy (Suga 2002).
Recent 129Xe MRI safety studies demonstrated that the
gas concentrations compatible with MRI are well tolerated
in healthy subjects and those with respiratory disease
(Driehuys et al. 2012; Shukla et al. 2012). Previous work
showed that 129Xe ADC (b = 12 sec/cm2; Kaushik et al.
2011) and 129Xe ADC morphometry measurements
(Ouriadov et al. 2013) provide a way to distinguish
between age-matched subjects with and without COPD.
Moreover, although strong and significant correlations for
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Materials and Methods
Subjects
All subjects provided written informed consent to the
study protocol that was approved by the local research
ethics board and Health Canada. COPD subjects were exsmokers with a smoking history of at least 10 pack-years
between 50 and 85 years of age and categorized according
to the Global Initiative for Chronic Lung Disease (2013)
(GOLD) spirometry criteria. Healthy older never-smokers
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the American Physiological Society and The Physiological Society.

M. Kirby et al.

(<1 pack-year over their lifetime and no smoking in last
20 years) were enrolled who had no history of previous
chronic or current respiratory disease.

Pulmonary function tests
A body plethysmograph (MedGraphics Corporation, Saint
Paul, MN) with the attached gas analyzer was used to
measure airflow, lung volumes, and DLCO according to
ATS/ERS guidelines (Macintyre et al. 2005; Miller et al.
2005; Wanger et al. 2005).

Image acquisition
Magnetic resonance imaging was performed on a whole
body 3.0 Tesla Discovery 750MR (General Electric Health
Care, Milwaukee, WI) MRI system with broadband imaging capability. Subjects were instructed to inhale a gas
mixture from a 1.0L Tedlar bag (Jensen Inert Products,
Coral Springs, FL) from functional residual capacity
(FRC) and image acquisition was performed under
breath-hold conditions (Parraga et al. 2007).
Hyperpolarized 3He MRI was enabled using a linear
bird-cage transmit/receive chest coil (RAPID Biomedical
GmbH, Wuerzburg, Germany; Farag et al. 2012). A turnkey system (HeliSpinTM, Polarean Inc, Durham, NC) was
used to polarize 3He gas to 30–40% and doses (5 mL/kg
body weight) diluted with N2 were administered in 1.0L
Tedlar bags. Hyperpolarized 3He MRI diffusion-weighted
imaging was performed using a 2D multislice fast gradientrecalled echo sequence (FGRE; 14 sec total data acquisition,
repetition time [TR]/echo time [TE]/flip angle = 7.6 msec/
3.7 msec/8°, field of view [FOV] = 40 9 40 cm, matrix
128 9 128, seven slices, 30 mm slice thickness, 0 gap)
during breath hold (Parraga et al. 2007) for acquisition of
two interleaved images with and without additional
diffusion sensitization with b = 1.6 sec/cm2 (maximum
gradient amplitude [G] = 1.94 G/cm, rise and fall
time = 0.5 msec, gradient duration = 0.46 msec, diffusion
time = 1.46 msec).
Hyperpolarized 129Xe MRI was enabled using a custommade, quadrature-asymmetric bird-cage coil model tuned
to 35.34 MHz, as described previously (Farag et al. 2012).
The XeBox-E10 polarizer system (XeBox-E10; Xemed
LLC, Durham, NH) was used to polarize the 129Xe gas
(86% enriched) to 10–60%. In contrast to the 3He gas
doses which were determined according to the subjects’
body weight, for 129Xe MRI a 50/50 mixture of 129Xe and
4
He gas was obtained by dispensing 129Xe directly into
1.0L Tedlar bags prefilled with 4He. Polarization of the
diluted dose was quantified with use of a Polarimeter (Polarean, Durham, NC). 129Xe MRI DW images were
obtained using a 2D multislice FGRE sequence; two inter-
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leaved images (16 sec total data acquisition, TE/TR/flip
angle = 9.8 msec/11.0 msec/5°, bandwidth = 31.25 kHz,
FOV = 40 9 40 cm, matrix 128 9 80, seven slices,
30 mm slice thickness, 0 gap) with and without additional
diffusion sensitization with b = 12 sec/cm2 (G = 2.90
G/cm, rise and fall time = 0.5 msec, gradient separation = 2.0 msec, gradient duration = 2.0 msec, diffusion
time = 5 msec), b = 20 sec/cm2 (G = 3.75 G/cm, rise and
fall time = 0.5 msec, gradient separation = 2.0 msec, gradient duration = 2.0 msec, diffusion time = 5 msec), and
b = 30 sec/cm2 (G = 4.60 G/cm, rise and fall time =
0.5 msec, gradient separation = 2 msec, gradient duration = 2.0 msec, diffusion time = 5 msec) were acquired
in separate image acquisitions, as described previously
(Kirby et al. 2012d; Boudreau et al. 2013).
Computed tomography was performed on a 64-slice
Lightspeed VCT scanner (GEHC, Milwaukee, WI). A single spiral acquisition of the entire lung was acquired from
apex to base with subjects in breath-hold condition after
inhalation of N2 from a 1.0L Tedlar bag (detector configuration of 64 9 0.625 mm, 120 kVp, 100 effective mA,
tube rotation time of 500 msec, and a pitch of 1.0).
Reconstruction of the data was performed using a standard convolution kernel and a slice thickness of 1.25 mm.

Image analysis
3

He ADC and 129Xe ADC with b values of 12 sec/cm2
(ADCb12), 20 sec/cm2 (ADCb20), and 30 sec/cm2
(ADCb30) were generated as described previously (Kirby
et al. 2012b). Briefly, we first segmented the 3He MRI
non-DW images using k-means cluster algorithm as
described previously for 3He MRI segmentation (Kirby
et al. 2012a). The segmented binary mask for the nonDW images was applied to the DW images. The ADC
maps were generated on a voxel-by-voxel basis according
to equation (1):
 
1
S0
(1)
ADC ¼ ln
b
S
where b = 1.6 sec/cm2, S0 = the segmented non-DW
image, and S = the diffusion-weighted image. The regional differences in ADC were evaluated for all AP coronal
slices and for each coronal slice in three SI regions of
interest (ROIs). The AP gradient (APG) was defined as
the slope of the line of best fit that described the change
in ADC as a function of distance in centimeters for all
slices in the anterior to posterior direction. The three SI
ROI were generated by dividing the center coronal slice
into three equivalent ROIs from apex to base and applying those boundaries to all slices. ΔSI was the mean
change in ADC in the superior and inferior ROI. To
compare 3He and 129Xe ADC ΔSI and APG to better
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understand any dependency on b value for regional ADC
differences in the respective gases, we compared the older
never-smokers to the COPD subjects, as well as to only
the COPD ex-smokers with emphysema. COPD subjects
without emphysema are unlikely to show an increased
3
He or 129Xe ADC ΔSI and APG difference compared to
the older never-smokers. The SNR for 3He and 129Xe DW
images and nondiffusion-weighted (NDW) images were
determined by calculating the mean voxel value within a
5 9 5 voxel ROI for four representative ROI within the
lung parenchyma, and dividing by the standard deviation
of the mean voxel values for four representative 5 9 5
voxel ROI within the image background where there was
no lung structure, for each slice. SNR was determined for
each slice and then averaged to obtain a single SNR value
for each subject image.
Quantitative CT measurements were performed using
the Pulmonary Workstation 2.0 (VIDA Diagnostics, Inc.,
Coralville, IA); the relative area with attenuation values
below 950 Hounsfield Units (HU; RA950), 910 HU
(RA910), and 856 HU (RA856) were generated (Gevenois
et al. 1996) as well as the CT HU value at which 15% of
the voxels in the frequency distribution histogram have a
lower density (HU15%). A CT density threshold for
emphysema of RA950 > 6.8% was adopted based on a previous study that reported RA950 = 6.8% as the upper 95%
limit of predicted normal values (Gevenois et al. 1996).
Qualitative visual scoring was also performed by an
expert chest radiologist (R. E.-R.) using a method adapted
from Bankier et al. (1999). Emphysema scores were based
on the percentage of low attenuation, tissue destruction,
and vascular disruption.

Statistical methods
A Mann–Whitney unpaired two-tailed t-test was performed for statistical comparison of all pulmonary function measurements, 3He and 129Xe ADC, 3He and 129Xe
ADC APG, and 3He and 129Xe ADC SI using GraphPad
Prism version 4.00 (GraphPad Software Inc., San Diego,
CA). A one-way analysis of variance (ANOVA) was used
for statistical comparison of the mean SNR values for
ADC DW images for 3He and 129Xe with all three b values using IBM SPSS Statistics 20.0 (SPSS Inc., Chicago,
IL). Linear regression (r2) and Pearson correlation coefficients (r) were used to determine the relationships
between imaging and other measurements using GraphPad. A Holm–Bonferroni correction (Van Bell et al. 2004)
was used to correct for multiple tests. Multivariate linear
regression modeling was used to evaluate the relationship
between DLCO and 3He ADC, 129Xe ADCb12, 129Xe
ADCb20, and 129Xe ADCb30 as well as between CT density
measurements and 3He ADC, 129Xe ADCb12, 129Xe
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ADCb20, and 129Xe ADCb30 using PROC REG in SAS 
9.2 Software (SAS Institute Inc., Cary, NC). In all statistical analyses, results were considered significant when the
probability of making a Type I error was <5% (P < 0.05).

Results
Study subjects and pulmonary function
Table 1 shows all demographic and pulmonary function
measurements for four older never-smokers and 10
COPD ex-smokers (GOLD Class I: n = 1; GOLD Class II:
n = 6; GOLD Class III: n = 2; GOLD Class IV: n = 1).
Although there were no significant differences in age, sex,
or BMI, the never-smokers and COPD ex-smokers were
significantly different with respect to FEV1 (P = 0.01),
FEV1/FVC (P = 0.002), TLC (P = 0.02), RV (P = 0.02),
FRC (P = 0.01), and DLCO (P = 0.006).

CT measurements of emphysema
Table 2 shows mean CT density thresholds (RA950, RA910,
RA856, HU15%) and CT emphysema scores for the COPD
ex-smokers, by subject. For all COPD ex-smokers, mean
RA950, RA910, RA856, HU15%, and emphysema score were
18.8  14.1%, 39.6  20.6%, 65.0  16.0%, 948 

Table 1. Subject demographics and pulmonary function measurements.

Age years (SD)
Female sex
Weight kg (SD)
BMI kg/m2 (SD)
FEV1%pred (SD)
FVC%pred (SD)
FEV1/FVC (SD)
TLC%pred (SD)
RV%pred (SD)
RV/TLC (SD)
IC%pred (SD)
FRC%pred (SD)
DLCO%pred (SD)

Older neversmokers
(n = 4)

All COPD
(n = 10)

COPD with
emphysema
(n = 7)

67
2
72
26.4
103
102
0.76
102
102
0.39
113
93
104

74
2
77
25.4
57
91
0.46
115
159
0.53
85
141
41

74
2
68
23.6
52
92
0.40
118
167
0.55
77
154
36

(13)
(11)
(2.8)
(6)
(8)
(0.02)
(8)
(9)
(0.09)
(16)
(15)
(12)

(4)
(22)
(5.0)
(24)*
(19)
(0.14)*
(8)*
(46)*
(0.14)
(31)
(35)*
(17)*

(4)
(18)
(4.6)
(27)*
(22)
(0.13)*
(7)*
(54)
(0.16)
(32)
(34)*
(13)*

SD, standard deviation; BMI, body mass index; FEV1, forced expiratory volume in 1 sec; %pred, percent predicted; FVC, forced vital
capacity; TLC, total lung capacity; RV, reserve volume; IC, inspiratory capacity; FRC, functional residual capacity; DLCO, carbon
monoxide diffusion capacity of the lung.
*Significant difference (P < 0.05) between older never-smokers
and chronic obstructive pulmonary disease (COPD) subjects.
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He ADCb
(cm2/sec)

3
= 1.6

= 20

= 30

–
–
–
–
–
–
0.064
0.055
–
0.052
0.057 (0.006)

0.040
0.035
0.036
0.042
0.038 (0.003)

Xe ADCb
(cm2/sec)

129

33.33
5.26
32.07
1.53
36.83
34.25
12.12
16.77
2.12
13.22
18.75 (14.11)

–
–
–
–
–

RA950 (HU)

49.35
30.43
65.81
9.13
66.19
60.48
31.56
40.14
13.38
29.00
39.55 (20.56)

–
–
–
–
–

RA910 (HU)

67.78
67.90
85.86
36.68
84.28
79.03
60.64
66.75
47.61
53.02
64.95 (15.95)

–
–
–
–
–

RA856 (HU)

CT measurements

981
930
972
895
975
977
943
954
907
945
948 (30)

–
–
–
–
–

HU15% (HU)

2.35
0.16
1.55
0.43
0.89
–
0.83
1.40
0.34
1.49
1.05 (0.71)

–
–
–
–
–

Visual score

3

He and

ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.

129

ADC, apparent diffusion coefficient; SNR, signal-to-noise ratio; RA950, relative area with attenuation values below 950 HU; RA910, relative area with attenuation values below 910 HU;
RA856, relative area with attenuation values below 856 HU; HU15%, the hounsfield unit value at which 15% of the voxels in the frequency distribution histogram have a lower density.

0.081
0.057
0.078
0.050
0.088
0.070
0.079
0.072
0.046
0.076
0.070 (0.014)

Xe ADCb
(cm2/sec)

129

Chronic obstructive pulmonary disease Ex-Smokers
1
0.611
0.096
2
0.305
0.057
3
0.531
0.087
4
0.320
0.058
5
0.591
0.095
6
0.617
0.095
7
0.504
0.085
8
0.474
0.083
9
0.283
0.056
10
0.526
0.092
All (SD)
0.476 (0.128)
0.080 (0.017)

= 12

0.048
0.049
0.049
0.053
0.044 (0.002)

Xe ADCb
(cm2/sec)

129

ADC measurements

Xe magnetic resonance imaging ADC and computed tomography (CT) measurements.

129

0.048
0.049
0.049
0.053
0.050 (0.002)

Older never-smokers
1
0.247
2
0.230
3
0.215
4
0.242
All (SD)
0.223 (0.014)

Subject

Table 2. Subject listing of 3He and
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30 HU, and 1.1  0.7, respectively, consistent with
mild emphysema. Subjects 2 (RA950 = 5.3%), 4 (RA950 =
1.5%), and 9 (RA950 = 2.1%) did not have CT evidence
of emphysema (RA950 < 6.8%). For only the COPD
ex-smokers with emphysema, mean RA950, RA910, RA856,
HU15%, and visual CT scoring measurements were
25.5  10.9%, 48.9  15.8%, 71.1  12.4%, 964  16
HU, and 1.4  0.6, respectively.

Hyperpolarized MRI ADC
Figure 1 shows the central coronal 3He ADC, 129Xe
ADCb12, 129Xe ADCb20, and 129Xe ADCb30 maps for an
older never-smoker and two COPD ex-smokers. ADC
maps appear brighter and more heterogeneous for the
COPD ex-smokers in comparison with the healthy neversmoker for 3He MRI as well as for 129Xe MRI for all b
values. As shown in Figure 2, there were statistically significantly greater ADC values for all COPD ex-smokers as
well as only those COPD ex-smokers with emphysema in
comparison to the older never-smokers for 3He ADC (all
COPD: P = 0.002; COPD with emphysema: P = 0.006),
129
Xe ADCb12 (all COPD: P = 0.002; COPD with emphysema: P = 0.006), and 129Xe ADCb20 (all COPD:
P = 0.04; COPD with emphysema: P = 0.006), but not
for 129Xe ADCb30 (P = 0.06).

For all subjects, mean SNR was statistically significantly
greater for 3He DW images (3He DW SNR = 34  19) in
comparison with 129Xe DW images with b value = 12 sec/
cm2 (129Xe DW SNR = 12  7, P < 0.0001), b value =
20 sec/cm2 (129Xe DW SNR = 10  7, P < 0.0001), and
b value = 30 sec/cm2 (129Xe DW SNR = 4  1, P <
0.0001), however, there was no significant difference
between mean 129Xe DW SNR for all b values (P > 0.05).
Importantly, for all subjects there was no significant correlation between SNR and ADC for 3He (r = 0.32,
P = 0.27), 129Xe ADCb12 (r = 0.47, P = 0.09), and 129Xe
ADCb20 (r = 0.50, P = 0.07), however, there was a significant correlation between SNR and 129Xe ADCb30
(r = 0.84, P = 0.02). For all subjects, mean SNR was statistically significantly greater for 3He NDW, or b = 0,
images (3He NDW SNR = 65  39) than for 129Xe NDW
images with b value = 12 sec/cm2 (129Xe NDW
SNR = 29  21, P = 0.008), b value = 20 sec/cm2 (129Xe
NDW SNR = 33  26, P = 0.02), and b value = 30 sec/
cm2 (129Xe NDW SNR = 18  11, P = 0.003), however,
there was no significant difference between mean 129Xe
NDW SNR for all b values (P > 0.05).

ADC regional differences
Figure 3 shows the 3He and 129Xe MRI ADC anterior–
posterior gradients (APG) for older never-smokers as well

Figure 1. Hyperpolarized 3He apparent diffusion coefficient (ADC) and 129Xe ADC maps for a representative older never-smoker and two
chronic obstructive pulmonary disease (COPD) ex-smokers. 3He ADC and 129Xe ADC maps with b value of 12 sec/cm2 (ADCb = 12), 20 sec/cm2
(ADCb = 20), and 30 sec/cm2 (ADCb = 30) of the coronal center slice for an older never-smoker (79-year-old male, FEV1 = 96%pred, FEV1/
FVC = 74%) and two COPD ex-smokers (top: 71-year-old male, FEV1 = 107%pred, FEV1/FVC = 58%; bottom: 76-year-old male,
FEV1 = 35%pred, FEV1/FVC = 31%).
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Figure 2. 3He and 129Xe magnetic resonance imaging apparent diffusion coefficient (ADC) measurements for older never-smokers, all chronic
obstructive pulmonary disease (COPD) ex-smokers, and COPD ex-smokers with emphysema. Box-and-Whisker plot where box extends from the
25th to 75th percentiles of ADC values, the line within the box is the median ADC value and error bars are the minimum and maximum ADC
values. Significance of difference (P < 0.05) determined using a Mann–Whitney unpaired two-tailed t-test.

as all COPD ex-smokers and only the COPD ex-smokers
with emphysema. There were statistically significantly
greater APG for the COPD ex-smokers than the older
never-smokers for 129Xe ADCb12 (P = 0.04) and 129Xe
ADCb20 (P = 0.04), but not for 3He ADC (P > 0.05) or
129
Xe ADCb30 (P > 0.05); there were also statistically significantly greater APG for the COPD ex-smokers with
emphysema than the older never-smokers for 3He ADC
(P = 0.02), 129Xe ADCb12 (P = 0.006), and 129Xe ADCb20
(P = 0.01), but not for 129Xe ADCb30 (P > 0.05).
Figure 4 shows the ADC in the superior and inferior
ROI for the older never-smokers, all COPD ex-smokers
and only the COPD ex-smokers with emphysema. For the
COPD ex-smokers with emphysema, mean 3He ADC was
statistically significantly greater in the superior ROI than
the inferior ROI (P = 0.04), however, there were no other
significant SI ADC differences in 3He or 129Xe MRI.

ADC relationships with pulmonary function
and CT
Figure 5 shows Pearson correlations for DLCO with 3He
ADC, 129Xe ADCb12, 129Xe ADCb20, and 129Xe ADCb30 for
all subjects. There were significant correlations for DLCO

with 3He ADC (r = 0.95, P = 0.003), 129Xe ADCb12
(r = 0.95, P = 0.002), and 129Xe ADCb20 (r = 0.87,
P = 0.01), however, the correlation for DLCO with 129Xe
ADCb30 (r = 0.89, P = 0.008 uncorrected, P = 0.10 corrected) was no longer significant following Holm–Bonferroni correction.
The Pearson correlation coefficients between CT lung
density thresholds (RA950, RA910, RA856, HU15%) and
visual CT emphysema scores are shown in Table 3. Following Holm–Bonferroni correction, 3He ADC was significantly correlated with RA950 (r = 0.90, P = 0.008) and
HU15% (r = 0.92, P = 0.004); 129Xe ADCb12 was significantly correlated with RA950 (r = 0.85, P = 0.03) and
HU15% (r = 0.90, P = 0.008); 129Xe ADCb20 was significantly correlated with HU15% (r = 0.86, P = 0.02);
129
Xe ADCb30 was not significantly correlated with any
CT emphysema measurements.
Table 4 shows the results of multiple linear regression
models with 3He ADC, 129Xe ADCb12, 129Xe ADCb20, and
129
Xe ADCb30 as the predictor variables. In the multivariate regression model for DLCO with 3He and all 129Xe
ADC values included, 129Xe ADCb12 (P = 0.049) was the
only significant predictor. In the multivariate regression
model for RA950 with 3He and all 129Xe ADC values
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Figure 3. 3He and 129Xe magnetic resonance imaging apparent diffusion coefficient (ADC) anterior–posterior gradients (APG) for older neversmokers, all chronic obstructive pulmonary disease (COPD) ex-smokers, and COPD ex-smokers with emphysema. Box-and-Whisker plot where
box extends from the 25th to 75th percentiles of ADC values, the line within the box is the median ADC APG value and error bars are the
minimum and maximum ADC APG values. Significance of difference (P < 0.05) determined using a Mann–Whitney unpaired two-tailed t-test.

included, the only significant predictor was 3He ADC
(P = 0.03). We also evaluated the multivariate regression
model for HU15%, and although the overall model was
statistically significant (P < 0.05), 3He ADC, 129Xe
ADCb12, or 129Xe ADCb20 were not significant predictors.

Discussion
The low and variable polarization levels and low diffusivity of 129Xe gas results in technical challenges for extracting physiologically meaningful pulmonary microstructural
information based on 129Xe MRI. Moreover, although
previous studies (Kaushik et al. 2011; Kirby et al. 2013,
2012d) reported 129Xe ADC based on a b value of 12 sec/
cm2, it is still unclear how to provide the optimal balance
between sensitivity to the lung microstructural abnormalities in emphysematous patients and feasibility with
respect to image quality. Moreover, 129Xe MRI ADC generated using different b values may access different
regions of the lung and likely probe different lung microstructure length scales thereby providing somewhat different spatial information relative to 3He ADC. For a better
understanding of these measurements, we investigated the
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different 129Xe MRI ADC b values and their associations
with anatomical and physiological measurements of
COPD in a small but well-characterized group of older
never-smokers and COPD ex-smokers.
We observed (i) significantly greater ADC values for
COPD ex-smokers compared to older never-smokers for
3
He ADC, 129Xe ADCb12, and ADCb20, but not for 129Xe
ADCb30, (ii) significantly greater anterior–posterior ADC
differences in COPD ex-smokers with emphysema compared to older never-smokers for 3He ADC, 129Xe
ADCb12, and ADCb20, but not for 129Xe ADCb30, (iii)
significantly different mean ADC in the superior as compared to inferior lung regions between older neversmokers and COPD ex-smokers for 3He ADC, but not for
129
Xe ADC, and finally, (iv) strong and significant correlations for 3He and 129Xe ADC with DLCO and CT measurements of emphysema, but in a multivariate model,
129
Xe ADCb12 was the only significant predictor of DLCO
and 3He ADC was the only significant predictor of CT
measured RA950.
As expected, we observed significantly greater (worse)
ADC for COPD ex-smokers than for older never-smokers
for 3He, and as well for 129Xe ADCb12 and ADCb20, but
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Figure 4. 3He and 129Xe magnetic resonance imaging (MRI) apparent diffusion coefficient (ADC) for superior and inferior regions of interest in
older never-smokers, all chronic obstructive pulmonary disease (COPD) ex-smokers, and COPD ex-smokers with emphysema. There was a
significant difference in mean ADC in the superior to inferior lung regions between the older never-smokers and the COPD ex-smokers with
emphysema for 3He MRI ADC (P = 0.04), but there were no other significant differences. Significance of difference (P < 0.05) determined using
a Mann–Whitney unpaired two-tailed t-test.

not for 129Xe ADCb30. There was a large difference in
mean ADC between subject subgroups for both 3He and
129
Xe MRI, and this important finding suggested that
both 129Xe MRI generated using b values of 12 and
20 sec/cm2 provide adequate sensitivity to lung microstructural abnormalities. These data are also in agreement
with previous findings (Kaushik et al. 2011) that 129Xe
ADCb12 can be used to distinguish between older neversmokers and COPD subjects with emphysema. However,
we must point out that 129Xe ADCb30 was not significantly different between subject subgroups and this may
have been due to the low sample size as well as low SNR.
For ADCb30, we demonstrated that the diffusion attenuation curves deviate from single exponential behavior after
b = 20 sec/cm2, suggesting greater diffusion anisotropy
(Ouriadov et al. 2013) compared to ADCb12 and ADCb20,
and this greatly influences image quality, which was poor
for ADCb30 images here. It is important to note that
while SNR was not significantly different for 129Xe MRI
acquired at all three b values, there was a significant

correlation between image SNR and ADC for 129Xe
ADCb30 only, suggesting that there may have been inadequate image quality to derive reliable ADC measurements.
Clearly these are important considerations when optimizing and selecting pulse sequence parameters since image
signal is expected to be reduced when the gradient amplitude is increased.
Second, there were statistically significantly greater APG
for the COPD ex-smokers with emphysema than the
older never-smokers for 3He ADC, 129Xe ADCb12, and
ADCb20, but not for 129Xe ADCb30. DW MRI is sensitive
to changes in the lung microstructure (Saam et al. 2000;
Salerno et al. 2002) and is therefore an indirect measure
of airspace size. Since the DW images were acquired in
breath-hold condition in the supine position, the measurement of the ADC on a slice-by-slice basis can be
exploited to measure compression of the dependent lung
due to gravity. Several studies have reported lower ADC
values in the dependent (or posterior) lung slices relative
to the nondependent anterior lung slices for 3He MRI
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Figure 5. Correlations for 3He and 129Xe apparent diffusion coefficient (ADC) with DLCO in all subjects. DLCO was significantly correlated with
3
He ADC (r = 0.95, r2 = 0.90, P < 0.0001, Holm–Bonferroni corrected P = 0.003, y = 0.0044x + 0.69), 129Xe ADCb = 12 (r = 0.95,
r2 = 0.90, P < 0.0001, Holm–Bonferroni corrected P = 0.002, y = 0.00056x + 0.11), 129Xe ADCb = 20 (r = 0.87, r2 = 0.76, P = 0.0005,
Holm–Bonferroni corrected P = 0.01, y = 0.00042x + 0.088), and 129Xe ADCb = 30 (r = 0.89, r2 = 0.78, P = 0.008, Holm–Bonferroni
corrected P = 0.10, y = 0.00029x + 0.069). Dotted lines indicate the 95% limits of agreement.

Table 3. Correlations for 3He and 129Xe apparent diffusion coefficient (ADC) with computed tomography emphysema measurements for
chronic obstructive pulmonary disease ex-smokers.
Pearson correlation coefficients r (p/p1)
3

RA950 (HU)
RA910 (HU)
RA856 (HU)
HU15% (HU)
Visual Score
1

He ADC (cm2/sec)

0.90
0.82
0.67
0.92
0.79

(0.0004/0.008)
(0.004/0.06)
(0.04/0.32)
(0.0002/0.004)
(0.01/0.11)

129

Xe ADCb12 (cm2/sec)

0.85
0.77
0.63
0.90
0.76

(0.002/0.03)
(0.009/0.11)
(0.05/0.35)
(0.0004/0.008)
(0.02/0.20)

129

Xe ADCb20 (cm2/sec)

0.79
0.78
0.69
0.86
0.66

(0.006/0.09)
(0.008/0.11)
(0.03/0.27)
(0.001/0.02)
(0.05/0.30)

129

Xe ADCb30 (cm2/sec)

0.49
0.06
0.30
0.44
0.38

(0.68/1.00)
(0.96/0.96)
(0.81/1.00)
(0.71/1.00)
(0.75/1.00)

Holm–Bonferroni adjusted significance values.

(Fichele et al. 2004; Evans et al. 2007; Diaz et al. 2008)
and 129Xe MRI with b = 12 sec/cm2 (Kaushik et al.
2011), which is expected due to compression of the lung
parenchyma in healthy never-smokers. However, in subjects with emphysema, the gradient in alveolar expansion
in the gravity-dependent direction is reduced, in part,
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because of gas trapping (Evans et al. 2007; Diaz et al.
2008). The finding that 129Xe ADCb12 anterior–posterior
gradients were also reduced in the COPD ex-smokers
with emphysema in comparison to healthy never-smokers
is in agreement with these previous studies (Evans et al.
2007; Diaz et al. 2008; Kaushik et al. 2011). Furthermore,
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Table 4. Multivariate linear regression model for DLCO and computed tomography RA950 with 3He and 129Xe apparent diffusion
coefficient (ADC).

Variable

Parameter
estimate

Standard
error

Fold change

P-value

Model 1: DLCO
3
He ADCb1.6
129
Xe ADCb12
129
Xe ADCb20
129
Xe ADCb30

663.85
4974.20
1165.39
935.27

218.63
1153.94
795.22
539.89

3.04
4.31
1.47
1.73

0.09
0.049
0.28
0.23

Model 2: RA950
3
He ADCb1.6
129
Xe ADCb12
129
Xe ADCb20
129
Xe ADCb30

306.93
1821.20
292.72
–

107.64
929.23
370.07
–

2.85
1.96
0.79
–

0.03
0.10
0.46
–

Statistically significant P-values (P < 0.05) are presented in bold.

the finding that 129Xe ADCb20 anterior–posterior gradients were also reduced in the COPD ex-smokers with
emphysema in comparison to healthy never-smokers suggests that 129Xe MRI with b = 20 sec/cm2 also provides a
way to evaluate microstructural abnormalities.
Third, there was a significant difference in mean ADC
in the superior as compared to inferior lung regions
between the older never-smokers and the COPD exsmokers with emphysema for 3He ADC, but not for any
129
Xe ADC. It is important to note that in contrast with
the results reported here, previous studies evaluating the
129
Xe ADC SI gradients in older never-smokers demonstrated elevated ADC values in the inferior lung regions
(Sindile et al. 2007) or elevated ADC values the superior
lung regions (Kaushik et al. 2011). It is clear that because
of the lower diffusion coefficient of pure 129Xe gas, more
heterogeneous gas mixing within the lung is likely to
occur during image acquisition and this may, in part,
explain the discrepancies in these previous reports. However, the 129Xe/4He gas mixture used in this study may
have allowed more homogeneous mixing within the lung
resulting in the lower SI gradient seen in the older neversmokers, which is to be expected in healthy volunteers
without emphysema. Although it is unclear why elevated
ADC was demonstrated in the superior lung regions in
comparison to the inferior lung regions for 3He MRI, but
not for 129Xe MRI in the COPD ex-smokers with emphysema, these differences may be explained by the different
lung regions accessed by the gases, as shown in Figure 1,
due to the different densities and viscosities of the gas
mixtures. In this regard, we previously demonstrated significantly greater ventilation abnormalities for 129Xe MRI
than 3He MRI in the same COPD ex-smokers (Kirby
et al. 2012d). In a regional evaluation of 3He and 129Xe

129

Xe ADC in Never- and Ex-smokers

ADC, we showed that mean ADC in lung regions
accessed by 3He gas only were significantly greater than in
the remaining lung (Kirby et al. 2013), suggesting that
the more emphysematous lung regions filled more readily
with 3He as compared to 129Xe gas. By extension therefore, if here the 3He gas more readily filled the centrilobular emphysematous regions within the upper lobe, this
may explain the greater SI differences for 3He MRI. However, it is important to note that based on the estimated
self-diffusion coefficients for the 3He and 129Xe gas mixtures (0.211 and 0.826 cm2/sec for 129Xe/4He and 3He/N2,
respectively; Kirby et al. 2012d), 129Xe gas is a better estimate of room air, which has an estimated self-diffusion
coefficient of 0.218 cm2/sec, as compared to the 3He gas
mixture. Taken together this suggests that due to the different physical properties of 129Xe, the distribution of the
129
Xe gas mixture that is imaged during a breath-hold
condition may more accurately reflect the regional distribution of oxygen gas mixed in room air as compared to
3
He gas mixtures used during imaging.
Finally, we demonstrated strong and significant correlations for 3He ADC, 129Xe ADCb12, and ADCb20 with
DLCO and CT measurements of emphysema. DW gradients and diffusion time influence the measured ADC, and
more importantly, they influence the spatial scale that the
gas is probing (Woods et al. 2005). Therefore, 3He ADC
and 129Xe ADC with different b-values may provide different sensitivities to different lung microstructural environments and abnormalities. We investigated this by
evaluating the relationship for DLCO and CT lung density
thresholds with 3He and 129Xe ADC. We observed strong
correlations for 3He ADC, 129Xe ADCb12, and ADCb20,
further suggesting that 129Xe DW imaging is sensitive to
the same lung microstructural abnormalities as 3He ADC
with b value 1.6 cm2/sec. However, we must also note
that although strong and significant univariate correlations were observed for 3He and 129Xe ADC with DLCO,
in the multivariate regression model 129Xe ADCb12 was
the only significant predictor of DLCO. In contrast, 3He
ADC was the only significant predictor of RA950.
Although CT density-threshold measurements correlate
with pathology measurements of emphysema on resected
lung specimens (Avni et al. 1996), it has been suggested
that CT is not sensitive to subclinical or more mild
emphysema (Muller et al. 1988; Miller et al. 1989). DLCO,
on the other hand, despite low reproducibility, has been
shown to be a very sensitive measure of early or mild
subclinical emphysematous abnormalities. A recent study
demonstrated elevated levels of endothelial microparticles
in smokers with abnormally low DLCO but normal
spirometry (Gordon et al. 2011). Furthermore, in
ex-smokers without COPD, elevated 3He ADC, worse
symptoms and exercise capacity were reported in subjects
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with abnormal as compared to normal DLCO (Kirby et al.
2013). Since 129Xe gas has a lower diffusivity than 3He,
we hypothesized that 129Xe MRI with greater diffusion
weighting may be more sensitive to early or mild emphysema. The finding that 129Xe MRI was the only significant
predictor of DLCO lends support to this notion.
The diffusion time of 5 msec was selected for 129Xe
MRI (Sukstanskii and Yablonskiy 2012; Boudreau et al.
2013) in order to probe a similar spatial length scale as
3
He, and using this diffusion time, the characteristic diffusion lengths were approximately 0.49 and 0.46 mm for
3
He and 129Xe, respectively. For these diffusion lengths, it
is likely that both 3He and 129Xe gas atoms diffused
beyond a single alveolus (diameter ~0.20 mm; Ochs et al.
2004) to a distal respiratory bronchiole (diameter
~0.40 mm; Horsfield and Cumming 1968). Although the
majority of the COPD subjects evaluated in this study
had moderate-to-severe emphysema, future studies, perhaps with improved polarization levels, should investigate
the sensitivity of different 129Xe MRI imaging parameters,
including different diffusion weighting and diffusion
times, for evaluating emphysematous changes in subjects
with more mild disease. Importantly, in our previous
investigations we have demonstrated 129Xe MRI gas distribution measurements were more sensitive to airway
wall abnormalities in asthmatics (Svenningsen et al. 2013)
and to emphysematous bullae in COPD (Kirby et al.
2013). These findings suggest that due to the different
physical properties of 129Xe gas compared to 3He gas,
129
Xe may be more sensitive for the detection of airway
obstruction and may therefore also be more sensitive for
the detection of airway obstruction in patients with early
or subclinical disease. However, this will need to be confirmed in future 129Xe MRI investigations.
We also believe that 129Xe MRI DW imaging may provide increased sensitivity for evaluating emphysematous
changes in subjects with more mild disease. In this regard,
we must acknowledge that 129Xe ADCb30 may not provide
an appropriate estimate of emphysema in subjects with
moderate-to-severe disease. In regions of the lung with
significant emphysema, the 129Xe gas diffusion coefficient
is likely strong enough to destroy the MRI signal in that
region due to the greater 129Xe diffusion weighting, and
the only signal remaining in the lung will be from the
nonemphysematous lung microstructure. Therefore, the
measured ADC values will reflect the healthier lung
parenchyma, and not the emphysematous regions. However, in very early or mild subclinical disease, this may in
fact be advantageous, as any small increase in airspace
size will result in a reduction in signal intensity in the
DW images. 129Xe ADCb30, due to the greater diffusion
weighting may therefore provide greater sensitivity to
mild microstructural changes than 3He ADC or 129Xe
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ADCb12, although this cannot be ascertained by the current study.
We recognize that this work was limited by several factors. First, the small number of subjects evaluated and in
particular the small number of subjects in the 129Xe
ADCb30 group, certainly limits the generalizability of these
results. Another important limitation for both 3He and
129
Xe ADC measurements is that these cannot be reported
for the regions of the lung that are poorly or not ventilated. Such unventilated or poorly ventilated lung regions
may be due to small airway occlusion, mucous plugs, airway wall thickening and inflammation, severe emphysema, or bullous disease. Previous studies (Kaushik et al.
2011; Kirby et al. 2012a) comparing 3He and 129Xe in
COPD suggest that 129Xe gas distribution is sensitive to
emphysematous bullae, and this is another consideration
when performing 129Xe DW imaging in COPD subjects.
In summary, we evaluated 129Xe ADC b values of 12,
20, and 30 sec/cm2 in the same older never-smokers and
COPD ex-smokers and compared these with 3He ADC,
DLCO, and CT measurements of emphysema. We showed
that 3He ADC and 129Xe ADCb12 or ADCb20 distinguished
subjects with and without COPD. Although strong correlations for both 3He and 129Xe ADC were observed with
DLCO and CT measurements of emphysema, in a multivariate analysis 129Xe ADCb12 was the only significant predictor of DLCO. However, 129Xe ADCb30 may be
appropriate for evaluating subclinical or mild emphysema,
in this small group of older never-smokers and ex-smokers with moderate-to-severe emphysema, 129Xe ADCb12
provided a physiologically appropriate estimate of gas
exchange abnormalities and alveolar microstructure, providing good evidence to support future 129Xe MRI studies
of emphysema.
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